Lipodystrophy - Wikipedia, the free encyclopedia
10 Jun 2009 ... Lipodystrophy is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. ...
http://en.wikipedia.org/wiki/Lipodystrophy...
|
Side Effects of Anti-HIV Medications
and insulin resistance is called lipodystrophy syndrome. What causes lipodystrophy? ... lipodystrophy. However, the results of switching drugs ...
http://www.aidsinfo.nih.gov/ContentFiles/Lipodystrophy_FS_en...
|
OMIM - LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2
MIM #151660 · Text · Description · Clinical Features · Inheritance · Mapping · Molecular Genetics · Genotype/Phenotype Correlations · Pathogenesis ...
http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=151660...
|
Amylin Pharmaceuticals » Lipodystrophy Orphan Drug Program
Patients with severe lipodystrophy, a very rare metabolic condition, have abnormalities in adipose tissue (fat) distribution with loss of subcutaneous fat
. ...
http://www.amylin.com/research/pipeline/lipodystrophy-orphan...
|
Berardinelli-Seip Congenital Lipodystrophy -- GeneReviews -- NCBI ...
23 Aug 2007 ... Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part...
|
Berardinelli-Seip congenital lipodystrophy - Genetics Home Reference
Berardinelli-Seip congenital lipodystrophy is a rare condition characterized by a lack of fatty (adipose) tissue in the body. This lack of adipose tissue ...
http://ghr.nlm.nih.gov/condition=berardinelliseipcongenitall...
|
OMIM - LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2
MIM #269700 · Text · Description · Clinical Features · Clinical Management · Mapping · Heterogeneity · Molecular Genetics · Population Genetics ...
http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=269700...
|
A cohorts study of lipodystrophy in HIV infected patients treated ...
Background: Lipodystrophy is currently the most important side effect of the HAART, producing aesthetics alterations, hyperlipidemia, isquemic cardiopathy,
...
http://gateway.nlm.nih.gov/MeetingAbstracts/102240427.html...
|
Metabolic effects of rosiglitazone in HIV lipodystrophy: a ...
Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial. Hadigan C, Yawetz S, Thomas A, Havers F, Sax PE, Grinspoon S.
...
http://www.ncbi.nlm.nih.gov/pubmed/15148065...
|
FDG-PET for early detection of lipodystrophy in HIV-infected patients.
Background: Lipodystrophy, an important complication of HAART, is a clinical diagnosis with early features often presenting 12-16 months after initiation of
...
http://gateway.nlm.nih.gov/MeetingAbstracts/102276536.html...
|
